Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin microspheres versus minocycline for moderate to severe inflammatory acne
2006-003491-35Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acne vulgaris and inflammatory acne comparing Azithromycin microspheres with Minocycline (2 arms). Primary endpoint: Primary efficacy endpoint. Started Apr 2007; status: terminated.
02
Drugs
azithromycinminocycline
03
Conditions
acne vulgarisinflammatory acne
Beyond the preview
Go deeper on 2006-003491-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003491-35.